-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

419 Dynamin 2 (DNM2) and PACSIN2 Regulate Megakaryocyte Demarcation Membrane System Formation and Platelet Production in Concert

Platelet Activation and Biochemistry
Program: Oral and Poster Abstracts
Type: Oral
Session: 301. Platelet Activation and Biochemistry: Platelet Production and Function
Monday, December 7, 2015: 8:00 AM
W315, Level 3 (Orange County Convention Center)

Silvia Giannini, PhD1,2, Markus Bender, PhD3*, Fred G. Pluthero, PhD4*, Hilary Christensen, PhD4*, Richard Leung, PhD4*, Richard W. Lo, PhD4,5*, Jan Kormann, PhD6*, Markus Plomann, PhD6*, Walter H.A. Kahr, MD, PhD4,5 and Hervé Falet, PhD2,7

1Brigham and Women's Hospital, Boston, MA
2Department of Medicine, Harvard Medical School, Boston, MA
3Rudolf Virchow Center, University Clinic of Wuerzburg, Wuerzburg, Germany
4Program in Cell Biology, The Hospital for Sick Children, Toronto, ON, Canada
5Departments of Paediatrics and Biochemistry, University of Toronto, Toronto, ON, Canada
6Center for Biochemistry, University of Cologne Faculty of Medicine, Cologne, Germany
7Division of Hematology, Brigham and Women's Hospital, Boston, MA

Blood platelets are produced in the bone marrow by megakaryocytes (MKs) in a process that requires extensive intracellular membrane rearrangements. These include the formation of the demarcation membrane system (DMS), the surface-connected membrane extension that invaginates into the cell body and further develops to provide membranes for future platelets. The precise molecular mechanisms responsible for these unique membrane rearrangements remain poorly understood. We have recently shown that Dnm2fl/fl Pf4-Cre mice specifically lacking the large GTPase dynamin 2 (DNM2) in MKs develop severe macrothrombocytopenia due to impaired receptor-mediated endocytosis (RME) (Bender, Giannini et al. Blood. 2015;125(6):1014-1024). Specifically, Dnm2fl/fl Pf4-Cre MKs accumulate arrested endocytic clathrin-coated vesicles that obstruct DMS formation. The actin nucleating factor Arp2/3 complex and polymerized actin clustered with clathrin at sites of impaired RME in Dnm2fl/fl Pf4-Cre MKs. We hypothesized that a DNM2 partner recruits actin-regulatory proteins at sites of RME and investigated the contribution of the F-BAR protein PACSIN2, an internal component of the initiating DMS (Jurak Begonja, Pluthero et al. Blood. 2015;126(1):80-88), in DMS formation and platelet production, as PACSIN2 interacts with DNM2 and actin-regulatory proteins such as N-WASP and filamin A (FlnA). Pacsin2–/– mice developed mild thrombocytopenia with slightly enlarged and shallow platelets. The DMS appeared less well defined and platelet territories were not readily visualized in Pacsin2–/– MKs. Pacsin2–/– Dnm2fl/fl Pf4-Cre mice lacking both PACSIN2 and DNM2 in MKs were further generated to determine the contribution of PACSIN2 in clathrin and actin clustering in Dnm2fl/fl Pf4-Cre MKs. Strikingly, PACSIN2 genetic deletion significantly improved the severe thrombocytopenia of Dnm2fl/fl Pf4-Cre mice. Specifically, PACSIN2 deletion abrogated the accumulation of clathrin and actin clusters, thereby unclogging DMS formation, which appeared as elongated maze-like membrane tubules in Pacsin2–/– Dnm2fl/fl Pf4-Cre MKs. Our results show that DNM2 terminates PACSIN2-dependent actin polymerization that accompanies RME, thereby allowing membrane rearrangements required for DMS formation.

Disclosures: No relevant conflicts of interest to declare.

*signifies non-member of ASH